De'Andre Hunter

Current Sentiment

De'Andre Hunter's public standing has cratered to one of the more uncomfortable spots a veteran can occupy heading into an offseason — the sentiment surrounding him is firmly negative, trending up only slightly from an even grimmer place just weeks ago. The dominant narrative has shifted entirely away from what he can do on the court and toward a single uncomfortable question: can a franchise in Sacramento's position justify a contract extension for a player earning $23.3M AAV who just underwent season-ending eye surgery, the latest in a persistent series of injuries that have chipped away at any belief in his durability? His 2025-26 production — 13.7 PPG, 4.1 RPG, and 2.0 APG across 45 games — represents a C-level performance grade, meaning he's been a middling contributor even when healthy, and that context makes the injury-driven absence land harder than it would for a player clearly outperforming his contract. The timing is particularly damaging: Hunter's surgery arrived during what the data describes as a franchise-record losing streak for a Kings team that has since been reduced to cycling through low-cost signings like Killian Hayes and DaQuan Jeffries, optics that frame Hunter's absence not as a loss of a crucial piece but as a footnote in a broader organizational unraveling. The bottom line is that Hunter enters the offseason as a player whose narrative is defined by fragility and a stubborn gap between his pay grade and his production — and with the Kings sitting at 22-60 as a 14th seed in the West, there is no goodwill capital or playoff urgency to soften the scrutiny.